Peab AB (publ) (PEAB-B)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 94.00 |
|---|---|
| 52-week range | 73.15 – 106.90 |
| Return, 1 month / 3 months | −6.0% / +2.7% |
| Return, 1 year / 3 years | +26.5% / +137.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 23.7% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 20.91M SEK |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Peab is a construction and civil engineering company based in Sweden. It builds homes, commercial and public buildings, and infrastructure such as roads and bridges, and it carries out contract work for property developers, municipalities and other clients across the Nordic countries. The company also produces and supplies materials like asphalt and concrete, and it develops housing and other property projects of its own.
Peab AB (publ) trades under the code PEAB-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Peab AB (publ) (PEAB-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 94.00 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 100 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.3% | ||
| From 52-week high | -11.5% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 34.6% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 20.91M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −6.0% |
| 3 months | +2.7% |
| 6 months | +0.0% |
| 1 year | +26.5% |
| 3 years | +137.8% |
| 5 years | +19.0% |
Signals
| 50-day / 200-day average | 96.14 / 93.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | SEK 1.8000 |
| 27 Oct 2025 | SEK 1.2500 |
| 7 May 2025 | SEK 1.5000 |
| 7 May 2024 | SEK 1.5000 |
| 5 May 2023 | SEK 4.0000 |
| 6 May 2022 | SEK 5.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.